Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Anaptys Announces Participation in Upcoming Investor Conferences

By GlobeNewswire

SAN DIEGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza (imsidolimab) with Vanda, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences:

UBS Global Biopharma Conference 2026, London

  • Format – Fireside chat
  • Date and Time – Tuesday, November 17, 2026 at 4:40pm GMT / 11:40am ET
  • Participant – Daniel Faga, president and chief executive officer

Piper Sandler 38th Annual Healthcare Conference, New York

  • Format – Fireside chat and one-on-one investor meetings
  • Date and Time – Wednesday, December 2, 2026 at 8:00am ET
  • Participant – Chris Murphy, chief financial officer

9th Annual Evercore Healthcare Conference, Miami

  • Format – Fireside chat
  • Date and Time – Wednesday, December 2, 2026 at 10:50am ET
  • Participant – Daniel Faga, president and chief executive officer

Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at https://ir.anaptysbio.com/presentations-and-events. Replays of the webcasts will be available for at least 30 days following the events.

About Anaptys

Anaptys manages the financial collaborations for Jemperli with GSK and Quimilza with Vanda, with a focus on protecting and returning the value of its royalties to shareholders. To learn more, visit www.AnaptysBio.com or follow us on LinkedIn.

Contact:
Chris Murphy
Chief Financial Officer
investors@anaptysbio.com


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.